PHARMACY

Zydus receives FDA OK for Zituvio

Zituvio is used to treat adult patients with Type 2 diabetes mellitus.
Surescripts acquires ActiveRADAR

ActiveRADAR offers evidence-based, formulary-specific and medically accepted use-specific therapeutic alternatives.
Alembic unveils 2 generics

Alembic is launching generic Robinul and generic Adrucil.
Sun Pharma Canada’s Winlevi rolls out in Canada

Winlevi is the first and only topical androgen receptor inhibitor, and the newest Health Canada-approved formulation to target the hormonal component of acne in 40 years.
iA partners with Euclid Medical Products

iA’s NEXiA Enterprise Software Suite will integrate Euclid’s Axial Adherence Packaging Technology into centralized fulfillment solutions.
U.S. District Court dismisses Norwich’s lawsuit against the FDA over generic Xifaxan

Norwich asked the District Court to direct the FDA in granting immediate approval for generic Xifaxan (rifaximin) 550 mg.
NCPA commends SFC PBM reform package legislation

The new package includes provisions requiring the Centers for Medicare and Medicaid Services to define contract terms and conditions that are “reasonable and relevant” under Medicare Part D.
Healing the healthcare system

Empowering pharmacists to keep us healthy is critical for the industry.